Provided by Tiger Trade Technology Pte. Ltd.

Alexander's

246.11
-3.6600-1.47%
Post-market: 246.110.00000.00%19:26 EDT
Volume:30.48K
Turnover:7.53M
Market Cap:1.26B
PE:61.37
High:249.78
Open:249.59
Low:245.00
Close:249.77
52wk High:260.84
52wk Low:201.28
Shares:5.11M
Float Shares:2.13M
Volume Ratio:1.09
T/O Rate:1.43%
Dividend:18.01
Dividend Rate:7.32%
EPS(TTM):4.01
EPS(LYR):5.50
ROE:16.21%
ROA:3.09%
PB:13.85
PE(LYR):44.78

Loading ...

Alexander's publishes financial calendar update on upcoming quarterly results and call

Reuters
·
Apr 21

ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules

GlobeNewswire
·
Apr 18

ALX Oncology Names Jeff Knight Chief Development, Operating Officer

MT Newswires Live
·
Apr 13

Press Release: ALX Oncology Appoints Jeff Knight as Chief Development and Operating Officer

Dow Jones
·
Apr 13

Alexander’s announces annual shareholder meeting via virtual webcast

Reuters
·
Apr 08

Alexander's 731 Office One unit grants Bloomberg $57 million rent abatement at 731 Lexington Ave

Reuters
·
Apr 01

ALX Oncology CEO Makes Notable Move With Latest Stock Sale

TIPRANKS
·
Mar 24

ALX Oncology Initiated at Overweight by Wells Fargo

Dow Jones
·
Mar 19

Wells Fargo Initiates ALX Oncology at Overweight With $5 Price Target

MT Newswires Live
·
Mar 19

ALX Oncology Price Target Maintained With a $4.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 10

BRIEF-Alexander's To Sell Rego Park I For Net Proceeds Of $202 Million

Reuters
·
Mar 09

Should Atlas Arteria's 20c Payout Amid Softer Earnings Shift the Income Trade-Off for (ASX:ALX) Investors?

Simply Wall St.
·
Mar 05

Assessing Atlas Arteria (ASX:ALX) Valuation After 2025 Earnings Update And Second Half Distribution

Simply Wall St.
·
Mar 04

Compass Diversified Holdings Adds Eugene Kim and Glenn Richter to Board

Reuters
·
Mar 03

Assessing Alexander’s (ALX) Valuation After Vacancies Plan And Refinancing Shift Investor Outlook

Simply Wall St.
·
Mar 01

ALX Oncology Holdings Q4 Adj. EPS $(0.37) Misses $(0.36) Estimate

Benzinga
·
Feb 27

ALX Oncology Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update

GlobeNewswire
·
Feb 27

Press Release: ALX Oncology to Report Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026

Dow Jones
·
Feb 19

Alexander's Balances Weaker Earnings With Buybacks And Rising New York Occupancy

Simply Wall St.
·
Feb 12

Alexander’s (ALX) FFO Drop In Q4 2025 Challenges Income Focused Bullish Narratives

Simply Wall St.
·
Feb 11